Indianapolis Business Journal

West-side business leaders had high hopes that the IndyGo rapid-transit line slated for Washington Street would usher in a wave of economic development and improved infrastructure. Now that the line has been partially rerouted, Taylor Wooten reports, local leaders fear they’ve missed out on a once-in-a generation opportunity. Also in this week’s paper, John Russell has the story of a diabetes medication that Eli Lilly and Co. abandoned 12 years ago that since has ben resurrected by another pharma firm and has become one of the hottest new drugs on the market. And Susan Orr reports on an effort at Purdue University to train policymakers, diplomats and more on the ethics of technology.